Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06689410

Multimodal Biocollection Linked to the French Register of Intracranial Aneurysms

Led by Nantes University Hospital · Updated on 2026-05-29

1100

Participants Needed

26

Research Sites

N/A

Total Duration

On this page

Sponsors

N

Nantes University Hospital

Lead Sponsor

F

Federation of Medical Specialties

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are collecting detailed data and human samples linked to the French Intracranial Aneurysm Registry to improve understanding and management of intracranial aneurysms (ICA). The study aims to better classify ICA cases by combining genetic, imaging, and rupture information. This approach may help identify specific subgroups for improved diagnosis and risk assessment in both familial and general populations. Participants include adults with confirmed typical bifurcation ICAs verified by MRI or cerebral arteriography. The study gathers genetic mutation data, imaging of aneurysm and vascular structures, and clinical information. Blood or saliva samples are collected to support this data collection. The study includes both sporadic cases and families with multiple affected members, with screening using MRI and Time of Flight sequences. Participants will undergo imaging assessments and provide biological samples, with data collected over 36 months to develop a predictive model for ICA subtypes. Researchers will study arterial bifurcations, aneurysm characteristics, genetic mutations, and genotype-phenotype relationships. The study includes consent procedures and ensures participants are covered by social security. Safety monitoring excludes those with MRI contraindications, and participation involves ongoing data collection and evaluation.

CONDITIONS

Brief Title

Multimodal Biocollection Linked to the French Register of Intracranial Aneurysms

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults with a confirmed typical bifurcation intracranial aneurysm verified by MRI and/or cerebral arteriography
  • Aneurysm discovered less than a year ago with initial imaging available
  • Written consent obtained for study participation
  • Patient covered by a social security plan
  • For familial cases: index patients with at least one related family member affected, and adult family relatives with MRI screening
  • Written consent and social security coverage for family participants
Not Eligible

You will not qualify if you...

  • Known syndromic diagnoses causing intracranial aneurysms such as Marfan syndrome, Ehlers Danlos syndrome type II and IV, Moya-Moya syndrome, SMAD3-related obstructive sleep apnea, or Autosomal Dominant Cystic Fibrosis
  • Aneurysms that are dissecting, fusiform, associated with arteriovenous malformation, blister-like, or mycotic
  • Cerebral white matter pathology on MRI suggesting Col4a1 mutation
  • Patients under guardianship, conservatorship, or court protection
  • Contraindication to MRI scan

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Sample Collection

Duration - Up to 36 months

Participants provide blood or saliva samples for genetic and biological analysis.

Trial Site Locations

Total: 26 locations

1

Nantes University Hospital

Nantes, Loire-Atlantique, France, 44093

Actively Recruiting

2

CHU Amiens

Amiens, France

Not Yet Recruiting

3

CHU Angers

Angers, France

Not Yet Recruiting

4

CHU Besançon

Besançon, France

Not Yet Recruiting

5

CHU Bordeaux Hôpital Pellegrin

Bordeaux, France

Not Yet Recruiting

6

CHU de Brest

Brest, France

Not Yet Recruiting

7

CHU Caen-Normandie

Caen, France

Not Yet Recruiting

8

CHU Clermont-Ferrand

Clermont-Ferrand, France, 63000

Actively Recruiting

9

CHU Limoges

Limoges, France

Not Yet Recruiting

10

APHM

Marseille, France

Not Yet Recruiting

11

CHU de Montpellier

Montpellier, France

Not Yet Recruiting

12

CHRU de Nancy

Nancy, France

Not Yet Recruiting

13

GHU Paris - Hôpital Ste Anne

Paris, France

Not Yet Recruiting

14

Hôpital Fondation Rothschild

Paris, France

Not Yet Recruiting

15

Hôpital La Pitié Salpêtrière

Paris, France

Not Yet Recruiting

16

Hôpital Lariboisière

Paris, France

Not Yet Recruiting

17

CHU de Poitiers

Poitiers, France

Not Yet Recruiting

18

CHU de Reims

Reims, France

Not Yet Recruiting

19

CHU Rennes

Rennes, France

Not Yet Recruiting

20

CHU de Rouen

Rouen, France

Not Yet Recruiting

21

CHU St Etienne

Saint-Etienne, France

Not Yet Recruiting

22

Hôpitaux Universitaires de Strasbourg

Strasbourg, France

Not Yet Recruiting

23

Hôpital Foch

Suresnes, France

Not Yet Recruiting

24

HIA Sainte-Anne

Toulon, France

Not Yet Recruiting

25

CHU de Toulouse

Toulouse, France

Not Yet Recruiting

26

CHRU Tours Hôpital Bretonneau

Tours, France

Not Yet Recruiting

Loading map...

Research Team

R

Romain BOURCIER, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here